Patent · US Expired

2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone

US5494919A · kind A · utility

54Cited by
12References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 1994
Grant dateFeb 27, 1996
Priority date
Expiry dateOct 17, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to certain piperidine, pyrrolidine, and hexahydro-1H-azepine compounds of the general structural formula: ##STR1## wherein R.sub.1, R.sub.3, R.sub.4, R.sub.5, A, W, X, Y, and n axe as defined herein. These compounds promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which s are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such compounds as the active ingredient thereof are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.